Tirzepatide is a dual glucose-dependent insulinotropic polypeptide (GIP) and glucagon-like peptide-1 (GLP-1) receptor agonist approved by the FDA for the treatment of type 2 diabetes mellitus (under the brand name Mounjaro) and chronic weight management (under the brand name Zepbound)
Studies show Wegovy can help reduce body weight by up to 15% over 68 weeks, making it an effective choice for those seeking semaglutide weight loss in San Antonio
To better understand the challenges and nutritional strategies used in clinical practice, we spoke to nutritionist Priscila Moraes, who shares her experience in monitoring these patients and the results observed throughout treatment
Follow-up appointments are included in the monthly fee
Author: With over 16 years as a published, award-winning journalist, editor, and writer, Genni Burkhart's career has spanned politics, healthcare, law, business finance, technology, and news
Representative data of two experiments (n = 3, two-sided unpaired t-test)